Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-03-26 @ 3:18 PM
NCT ID:
NCT07380867
Eligibility Criteria:
Inclusion Criteria:
* Adult patients aged 19-80 years
* Clinical T1-2, N0, without distant metastasis on imaging
* If surgical treatment is required after ESD (endoscopic mucosal resection)\*
* If endoscopic lesion marking is required as determined by the attending physician
Exclusion Criteria:
* Patients diagnosed with distant metastases (M1)
* Severe hepatic or renal dysfunction (Child-Pugh Class C, eGFR \<39 mL/min/1.73 m2)
* Pregnant or lactating women
* High risk of intestinal obstruction or perforation
* Patients deemed inappropriate by the investigator (high-risk patients, such as patients with lung or heart disease, risk factors for bleeding, hepatitis virus infection, or other cancers)
* Patients with a history of hypersensitivity to the luminomarker drug or its components
* Patients who have experienced skin hypersensitivity to the dye
* Patients who do not wish to participate in the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Maximum Age:
80 Years
Study:
NCT07380867
Study Brief:
Protocol Section:
NCT07380867